Telehealth startup Cerebral under investigation over prescriptions for controlled substances
Mental health startup Cerebral is under investigation by the US Department of Justice over its prescribing of controlled substances like Adderall and Xanax. The company received a grand jury subpoena asking for documents from the US Attorney for the Eastern District of New York on May 4, Insider first reported.
Other Articles in this Edition
ADHD in adults is challenging but highly treatable – a clinical psychologist explains
5 Tips for Raising Kids with ADHD When You Have ADHD, Too
Telehealth startup Cerebral under investigation over prescriptions for controlled substances
New documentary aims to educate, reframe view of ADHD
ADHD and the COVID-19 Pandemic
The Unique Signs and Struggles of Adult ADHD
How Viloxazine Extended-Release Capsules Alter Adult ADHD Care